 |
|
|
|
|
|
 |
Company Information |
|
|
| Title |
 |
Publication Date |
 |
Price |
|
|
|
|
Illumina Inc
Premium Company Profile
|
April 2008 |
£265 |
Danaher Corporation
Premium Company Profile
|
April 2008 |
£265 |
Cytori Therapeutics Inc
Premium Company Profile
|
April 2008 |
£265 |
Csl Limited
Premium Company Profile
|
April 2008 |
£265 |
Incyte Corporation
Premium Company Profile
|
April 2008 |
£265 |
Introgen Therapeutics Inc
Premium Company Profile
|
April 2008 |
£265 |
Lev Pharmaceuticals Inc
Premium Company Profile
|
April 2008 |
£265 |
La Jolla Pharmaceutical Co
Premium Company Profile
|
April 2008 |
£265 |
Javelin Pharmaceuticals Inc
Premium Company Profile
|
April 2008 |
£265 |
Cougar Biotechnology Inc
Premium Company Profile
|
April 2008 |
£265 |
Carl Zeiss Meditec Ag
Premium Company Profile
|
April 2008 |
£265 |
Avigen Inc
Premium Company Profile
|
April 2008 |
£265 |
Antisoma plc
Premium Company Profile
|
April 2008 |
£265 |
Anesiva Inc
Premium Company Profile
|
April 2008 |
£265 |
Allos Therapeutics Inc
Premium Company Profile
|
April 2008 |
£265 |
Beckman Coulter Inc
Premium Company Profile
|
April 2008 |
£265 |
Becton, Dickinson and Co
Premium Company Profile
|
April 2008 |
£265 |
C.R. Bard Inc
Premium Company Profile
|
April 2008 |
£265 |
Boston Scientific Corporation
Premium Company Profile
|
April 2008 |
£265 |
Bioms Medical Corp
Premium Company Profile
|
April 2008 |
£265 |
Lexicon Pharmaceuticals Inc
Premium Company Profile
|
April 2008 |
£265 |
Kv Pharmaceutical Company
Premium Company Profile
|
April 2008 |
£265 |
St. Jude Medical Inc
Premium Company Profile
|
April 2008 |
£265 |
LifeCell Corporation
Premium Company Profile
|
April 2008 |
£265 |
Smith & Nephew plc
Premium Company Profile
|
April 2008 |
£265 |
Poniard Pharmaceuticals Inc
Premium Company Profile
|
April 2008 |
£265 |
Stryker Corporation
Premium Company Profile
|
April 2008 |
£265 |
Theratechnologies Inc
Premium Company Profile
|
April 2008 |
£265 |
Zimmer Holdings Inc
Premium Company Profile
|
April 2008 |
£265 |
Varian Medical Systems Inc
Premium Company Profile
|
April 2008 |
£265 |
Transition Therapeutics Inc
Premium Company Profile
|
April 2008 |
£265 |
TorreyPines Therapeutics Inc
Premium Company Profile
|
April 2008 |
£265 |
Panacos Pharmaceuticals Inc
Premium Company Profile
|
April 2008 |
£265 |
Spectrum Pharmaceuticals Inc
Premium Company Profile
|
April 2008 |
£265 |
Micromet Inc
Premium Company Profile
|
April 2008 |
£265 |
MannKind Corporation
Premium Company Profile
|
April 2008 |
£265 |
MorphoSys Ag
Premium Company Profile
|
April 2008 |
£265 |
Medtronic Inc
Premium Company Profile
|
April 2008 |
£265 |
Nuvelo Inc
Premium Company Profile
|
April 2008 |
£265 |
Novacea Inc
Premium Company Profile
|
April 2008 |
£265 |
Optimer Pharmaceuticals Inc
Premium Company Profile
|
April 2008 |
£265 |
Cadinal Health Medical Device Company Intelligence Report
|
April 2008 |
£395 |
Hillenbrand Medical Device Company Intelligence Report
|
April 2008 |
£395 |
Cytogen Corporation - SWOT Analysis
SWOT Analysis
|
April 2008 |
£63 |
Merck & Co., Inc. - SWOT Analysis
SWOT Analysis
|
April 2008 |
£63 |
Amgen Inc. - SWOT Analysis
SWOT Analysis
|
April 2008 |
£63 |
Shire plc - SWOT Analysis
SWOT Analysis
|
April 2008 |
£63 |
CollaGenex Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis
|
April 2008 |
£63 |
Cardinal Health, Inc. - SWOT Analysis
SWOT Analysis
|
April 2008 |
£63 |
Endo Pharmaceuticals Holdings Inc. - SWOT Analysis
SWOT Analysis
|
April 2008 |
£63 |
Santarus, Inc. - SWOT Analysis
SWOT Analysis
|
April 2008 |
£63 |
ISTA Pharmaceuticals, Inc. - SWOT Analysis
SWOT Analysis
|
April 2008 |
£63 |
Nastech Pharmaceutical Company Inc - SWOT Analysis
SWOT Analysis
|
April 2008 |
£63 |
Biogen Idec, Inc.
SWOT Analysis
|
April 2008 |
£63 |
Pfizer Inc
SWOT Analysis
|
April 2008 |
£63 |
Alcon
Pipeline,Products,Performance,Potential
|
March 2008 |
£595 |
Abbott Laboratories
Pipeline,Products,Performance,Potential
|
March 2008 |
£595 |
CollaGenex Pharmaceuticals, Inc. - SWOT Analysis
|
March 2008 |
£63 |
Wyeth - SWOT Analysis
|
March 2008 |
£63 |
Bayer Schering Pharma AG - SWOT Analysis
|
March 2008 |
£63 |
Schering-Plough Corporation - SWOT Analysis
|
March 2008 |
£63 |
Dyax Corp - SWOT Analysis
|
March 2008 |
£63 |
Pfizer Inc - SWOT Analysis
|
March 2008 |
£63 |
Iasis Healthcare LLC - SWOT Analysis
|
March 2008 |
£63 |
Hillenbrand Industries, Inc. - SWOT Analysis
|
March 2008 |
£63 |
Abbott Laboratories - SWOT Analysis
|
March 2008 |
£63 |
Progenics Pharmaceuticals Inc - SWOT Analysis
|
March 2008 |
£63 |
Shionogi:
Pipeline • Products • Performance • Potential
|
March 2008 |
£595 |
Gilead Sciences
Performance, Products, Pipeline and Potential
|
February 2008 |
£595 |
Ono: Pipeline • Products • Performance • Potential
|
February 2008 |
£595 |
Astellas Pharma
Performance, Products, Pipeline and Potential
|
February 2008 |
£595 |
GlaxoSmithKline Prospects to 2010
Pipeline, Products,Performance,Potential
|
February 2008 |
£595 |
Schering-Plough
Prospects to 2010
Prospects to 2010
|
February 2008 |
£595 |
Bristol-Myers Squibb
Pipeline, Products, Performance, Potential
|
February 2008 |
£595 |
Novartis
Pipeline Products Performance Potential
|
February 2008 |
£595 |
Takeda
Pipeline, Products,Performance,Potential
|
February 2008 |
£595 |
Allergan: Pipeline , Products , Performance , Potential
|
February 2008 |
£595 |
Siemens Medical Solutions - SWOT Analysis
|
February 2008 |
£63 |
Nobel Biocare Holding AG - SWOT Analysis
|
February 2008 |
£63 |
Schwarz Pharma AG - SWOT Analysis
|
February 2008 |
£63 |
OPG Groep - SWOT Analysis
|
February 2008 |
£63 |
Schering AG - SWOT Analysis
|
February 2008 |
£63 |
Roche Holding Ltd - SWOT Analysis
|
February 2008 |
£63 |
Charoen Pokphand Foods Public Company Limited - SWOT Analysis
|
February 2008 |
£63 |
Gambro AB - SWOT Analysis
|
February 2008 |
£63 |
Crucell N.V. - SWOT Analysis
|
February 2008 |
£63 |
CuraGen Corporation - SWOT Analysis
|
February 2008 |
£63 |
Essilor International S.A. - SWOT Analysis
|
February 2008 |
£63 |
DSM N.V. - SWOT Analysis
|
February 2008 |
£63 |
Boehringer Ingelheim GmbH - SWOT Analysis
|
February 2008 |
£63 |
BioMarin Pharmaceutical Inc - SWOT Analysis
|
February 2008 |
£63 |
Compagnie Generale des Etablissements Michelin - SWOT Analysis
|
February 2008 |
£63 |
Luxottica Group S.p.A. - SWOT Analysis
|
February 2008 |
£63 |
Sinochem - SWOT Analysis
|
February 2008 |
£63 |
E.ON - SWOT Analysis
|
February 2008 |
£63 |
BUPA - SWOT Analysis
|
February 2008 |
£63 |
Hartmann Group - SWOT Analysis
|
February 2008 |
£63 |
Merck KGaA - SWOT Analysis
|
February 2008 |
£63 |
Akzo Nobel N.V. - SWOT Analysis
|
February 2008 |
£63 |
EGIS Pharmaceuticals Plc - SWOT Analysis
|
February 2008 |
£63 |
Edison S.p.A. - SWOT Analysis
|
February 2008 |
£63 |
Shin-Etsu Chemical Co., Ltd. - SWOT Analysis
|
February 2008 |
£63 |
Solvay Group - SWOT Analysis
|
February 2008 |
£63 |
Ipsen - SWOT Analysis
|
February 2008 |
£63 |
Denki Kagaku Kogyo Kabushiki Kaisha - SWOT Analysis
|
February 2008 |
£63 |
Virbac Corporation - SWOT Analysis
|
February 2008 |
£63 |
Philips Medical Systems - SWOT Analysis
|
February 2008 |
£63 |
First Pacific Company Limited - SWOT Analysis
|
February 2008 |
£63 |
ICI plc - SWOT Analysis
|
February 2008 |
£63 |
International Specialty Products Inc - SWOT Analysis
|
February 2008 |
£63 |
GlaxoSmithKline Plc - SWOT Analysis
|
February 2008 |
£63 |
Johnson Matthey PLC - SWOT Analysis
|
February 2008 |
£63 |
Nippon Soda Co., Ltd. - SWOT Analysis
|
February 2008 |
£63 |
Linde AG - SWOT Analysis
|
February 2008 |
£63 |
Degussa AG - SWOT Analysis
|
February 2008 |
£63 |
Tosoh Corporation - SWOT Analysis
|
February 2008 |
£63 |
Boiron SA - SWOT Analysis
|
February 2008 |
£63 |
BASF Aktiengesellschaft - SWOT Analysis
|
February 2008 |
£63 |
A. Schulman, Inc. - SWOT Analysis
|
February 2008 |
£63 |
Protherics PLC - SWOT Analysis
|
February 2008 |
£63 |
Celesio AG - SWOT Analysis
|
February 2008 |
£63 |
Bayer AG - SWOT Analysis
|
February 2008 |
£63 |
Cytec Industries Inc. - SWOT Analysis
|
February 2008 |
£63 |
Pet Health Care in Sweden to 2011
|
February 2008 |
£265 |
Cypress Bioscience Inc: Premium Company Profile
|
February 2008 |
£265 |
Dynavax Technologies Corp: Premium Company Profile
|
February 2008 |
£265 |
Alexion Pharmaceuticals Inc: Premium Company Profile
|
February 2008 |
£265 |
Optimer Pharmaceuticals Inc: Premium Company Profile
|
February 2008 |
£265 |
Keryx Biopharmaceuticals: Premium Company Profile
|
February 2008 |
£265 |
Alexza Pharmaceuticals Inc: Premium Company Profile
|
February 2008 |
£265 |
Cytokinetics Inc: Premium Company Profile
|
February 2008 |
£265 |
Dendreon Corp -Therapeutic Competitors
|
February 2008 |
£175 |
Dyax Corp -Therapeutic Competitors
|
February 2008 |
£175 |
Dragon Pharmaceutical Inc -Therapeutic Competitors
|
February 2008 |
£175 |
EPIX Pharmaceuticals Inc -Therapeutic Competitors
|
February 2008 |
£175 |
DUSA Pharmaceuticals Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Depomed Inc -Therapeutic Competitors
|
February 2008 |
£175 |
DURECT Corporation -Therapeutic Competitors
|
February 2008 |
£175 |
Derma Sciences Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Dr Reddys Laboratories Ltd -Therapeutic Competitors
|
February 2008 |
£175 |
Dnaprint Genomics Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Duska Therapeutics Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Discovery Laboratories Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Dynavax Technologies Corp -Therapeutic Competitors
|
February 2008 |
£175 |
Diamyd Medical AB -Therapeutic Competitors
|
February 2008 |
£175 |
Dov Pharmaceutical Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Cytokinetics Inc -Therapeutic Competitors
|
February 2008 |
£175 |
CombinatoRx Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Columbia Laboratories Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Compugen Ltd -Therapeutic Competitors
|
February 2008 |
£175 |
Corcept Therapeutics Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Cougar Biotechnology, Inc. -Therapeutic Competitors
|
February 2008 |
£175 |
Cortex Pharmaceuticals Inc -Therapeutic Competitors
|
February 2008 |
£175 |
CollaGenex Pharmaceuticals Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Echo Therapeutics, Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Cleveland Biolabs Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Chugai Pharmaceutical Co Ltd -Therapeutic Competitors
|
February 2008 |
£175 |
Chemgenex Pharmaceuticals Ltd -Therapeutic Competitors
|
February 2008 |
£175 |
Clinical Data Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Cobalis Corp -Therapeutic Competitors
|
February 2008 |
£175 |
Clinuvel Pharmaceuticals Ltd -Therapeutic Competitors
|
February 2008 |
£175 |
Critical Therapeutics Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Crucell N V -Therapeutic Competitors
|
February 2008 |
£175 |
Cytogenix Inc -Therapeutic Competitors
|
February 2008 |
£175 |
CytoDyn Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Chemokine Therapeutics Corp -Therapeutic Competitors
|
February 2008 |
£175 |
Cytos Biotechnology AG -Therapeutic Competitors
|
February 2008 |
£175 |
DOR BioPharma Inc -Therapeutic Competitors
|
February 2008 |
£175 |
DENTSPLY International Inc -Therapeutic Competitors
|
February 2008 |
£175 |
CytRx Corporation -Therapeutic Competitors
|
February 2008 |
£175 |
Cypress Bioscience Incorporated -Therapeutic Competitors
|
February 2008 |
£175 |
CuraGen Corp -Therapeutic Competitors
|
February 2008 |
£175 |
Cubist Pharmaceuticals Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Curis Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Cyanotech Corporation -Therapeutic Competitors
|
February 2008 |
£175 |
Cyplasin Biomedical Ltd. -Therapeutic Competitors
|
February 2008 |
£175 |
Cyclacel Pharmaceuticals, Inc. -Therapeutic Competitors
|
February 2008 |
£175 |
DRAXIS Health Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Gilead Sciences Inc -Therapeutic Competitors
|
February 2008 |
£175 |
H.Lundbeck AS -Therapeutic Competitors
|
February 2008 |
£175 |
GlaxoSmithKline plc -Therapeutic Competitors
|
February 2008 |
£175 |
Chelsea Therapeutics International Ltd -Therapeutic Competitors
|
February 2008 |
£175 |
Halozyme Therapeutics Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Hana Biosciences Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Hemispherx Biopharma Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Helix BioMedix Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Geron Corporation -Therapeutic Competitors
|
February 2008 |
£175 |
GeoVax Labs Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Genitope Corp -Therapeutic Competitors
|
February 2008 |
£175 |
Generex Biotechnology Corporation -Therapeutic Competitors
|
February 2008 |
£175 |
Genta Incorporated -Therapeutic Competitors
|
February 2008 |
£175 |
Gentium S.p.A -Therapeutic Competitors
|
February 2008 |
£175 |
GeoPharma Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Genzyme Corporation -Therapeutic Competitors
|
February 2008 |
£175 |
Hemobiotech Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Hi -Tech Pharmacal Co Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Imagenetix Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Idera Pharmaceuticals Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Idenix Pharmaceuticals Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Imarx Therapeutics, Inc. -Therapeutic Competitors
|
February 2008 |
£175 |
Imclone Systems Inc -Therapeutic Competitors
|
February 2008 |
£175 |
ImmunoGen Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Immtech Pharmaceuticals Inc -Therapeutic Competitors
|
February 2008 |
£175 |
ISTA Pharmaceuticals Inc -Therapeutic Competitors
|
February 2008 |
£175 |
IMCOR Pharmaceutical Co. -Therapeutic Competitors
|
February 2008 |
£175 |
Hologic Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Hollis -Eden Pharmaceuticals Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Hospira Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Human Genome Sciences Inc -Therapeutic Competitors
|
February 2008 |
£175 |
IDM Pharma Inc -Therapeutic Competitors
|
February 2008 |
£175 |
ICAgen Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Genentech Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Genelabs Technologies Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Enzo Biochem Inc -Therapeutic Competitors
|
February 2008 |
£175 |
EntreMed Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Enhance Biotech Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Enzon Pharmaceuticals Inc -Therapeutic Competitors
|
February 2008 |
£175 |
EpiCept Corp -Therapeutic Competitors
|
February 2008 |
£175 |
Eqitx Ltd -Therapeutic Competitors
|
February 2008 |
£175 |
Epigenomics AG -Therapeutic Competitors
|
February 2008 |
£175 |
Endovasc Inc (NV) -Therapeutic Competitors
|
February 2008 |
£175 |
Endo Pharmaceuticals Holdings Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Eli Lilly & Co -Therapeutic Competitors
|
February 2008 |
£175 |
Elan Corp Plc -Therapeutic Competitors
|
February 2008 |
£175 |
Elite Pharmaceuticals Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Emergent BioSolutions Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Encysive Pharmaceuticals Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Emisphere Technologies Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Eugene Science Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Eurand N.V. -Therapeutic Competitors
|
February 2008 |
£175 |
GammaCan International Inc -Therapeutic Competitors
|
February 2008 |
£175 |
GW Pharmaceuticals PLC -Therapeutic Competitors
|
February 2008 |
£175 |
GTX INC -Therapeutic Competitors
|
February 2008 |
£175 |
Gedeon Richter Ltd -Therapeutic Competitors
|
February 2008 |
£175 |
GelStat Corp -Therapeutic Competitors
|
February 2008 |
£175 |
Genaera Corporation -Therapeutic Competitors
|
February 2008 |
£175 |
GenVec Inc -Therapeutic Competitors
|
February 2008 |
£175 |
GTC Biotherapeutics Inc -Therapeutic Competitors
|
February 2008 |
£175 |
GPC Biotech AG -Therapeutic Competitors
|
February 2008 |
£175 |
Favrille Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Exelixis Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Flamel Technologies SA ADS -Therapeutic Competitors
|
February 2008 |
£175 |
Forbes Medi -Tech Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Forticell Bioscience, Inc. -Therapeutic Competitors
|
February 2008 |
£175 |
Forest Laboratories Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Eisai Co Ltd -Therapeutic Competitors
|
February 2008 |
£175 |
Bio -Bridge Science Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Alpharma Inc -Therapeutic Competitors
|
February 2008 |
£175 |
AlphaRx Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Alnylam Pharmaceuticals Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Alseres Pharmaceuticals, Inc. -Therapeutic Competitors
|
February 2008 |
£175 |
Altus Pharmaceuticals Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Amarin Corporation plc -Therapeutic Competitors
|
February 2008 |
£175 |
Amarillo Biosciences Inc -Therapeutic Competitors
|
February 2008 |
£175 |
Allos Therapeutics Inc -Therapeutic Competitors
|
February 2008< |
